Anzeige
Mehr »
Login
Dienstag, 25.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
KI-Wunder? Diese Aktie verachtfacht sich nach Deepseek R1-Integration!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0EAT9 | ISIN: BE0003818359 | Ticker-Symbol: GXE
Tradegate
24.02.25
15:29 Uhr
25,540 Euro
-0,040
-0,16 %
Branche
Biotechnologie
Aktienmarkt
BEL-20
AMX
1-Jahres-Chart
GALAPAGOS NV Chart 1 Jahr
5-Tage-Chart
GALAPAGOS NV 5-Tage-Chart
RealtimeGeldBriefZeit
25,20025,44024.02.
25,20025,38024.02.
GlobeNewswire (Europe)
188 Leser
Artikel bewerten:
(1)

Galapagos NV: Galapagos to Present at Upcoming Investor Conferences

Finanznachrichten News

Mechelen, Belgium; February 24, 2025, 22:01 CET - Galapagos NV

Barclays 27th Annual Global Healthcare Conference
Date: Wednesday, March 12, 2025
Location: Miami, FL
Corporate Presentation: 11:00 - 11:25 AM ET / 5:00 - 5:25 PM CET
Live Webcast Link: Here

A live webcast of the presentations can also be accessed on the Investors page of the Company's website at www.glpg.com/investors. Replays of the webcasts will be available following the completion of the event and will be archived for up to 90 days.

About Galapagos


We are a biotechnology company with operations in Europe and the U.S. dedicated to transforming patient outcomes through life-changing science and innovation for more years of life and quality of life. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class medicines. With capabilities from lab to patient, including a decentralized cell therapy manufacturing platform, we are committed to challenging the status quo and delivering results for our patients, employees, and shareholders. Our goal is not just to meet current medical needs but to anticipate and shape the future of healthcare, ensuring that our innovations reach those who need them most. For additional information, please visit www.glpg.comor follow us on LinkedInor X.

For further information, please contact:

Media inquiries:
Srikant Ramaswami

+1 412 699 0359

Marieke Vermeersch

+32 479 490 603

media@glpg.com (mailto:media@glpg.com)
Investor inquiries:
Srikant Ramaswami

+1 412 699 0359

Sandra Cauwenberghs

+32 495 58 46 63


ir@glpg.com (mailto:ir@glpg.com)


Forward-looking statements

This press release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.

Attachment

  • GLPG - Investor Conferences Announcement_ENG (https://ml-eu.globenewswire.com/Resource/Download/1911bf24-1ac2-4404-8c2b-b919ef8d4ac7)

© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.